Analysts Set Teladoc Health, Inc. (NYSE:TDOC) Target Price at $12.24

Teladoc Health, Inc. (NYSE:TDOC) has received a consensus rating of “Hold” from the twenty-one brokerages that are presently covering the firm, MarketBeat reports. Fourteen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $12.24.

TDOC has been the subject of a number of recent analyst reports. Royal Bank of Canada increased their price target on Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. TD Cowen decreased their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Cantor Fitzgerald restated an “overweight” rating and set a $10.00 price target on shares of Teladoc Health in a report on Tuesday, August 20th. The Goldman Sachs Group began coverage on shares of Teladoc Health in a research report on Friday, November 15th. They issued a “buy” rating and a $14.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st.

Insider Activity

In other news, Director Thomas Mckinley bought 4,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were acquired at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the purchase, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. This represents a 11.40 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares in the company, valued at $34,477.70. This trade represents a 45.25 % decrease in their position. The disclosure for this sale can be found here. 0.95% of the stock is currently owned by insiders.

Institutional Trading of Teladoc Health

Several hedge funds have recently added to or reduced their stakes in TDOC. TCW Group Inc. bought a new stake in Teladoc Health in the 3rd quarter valued at $2,464,000. Geode Capital Management LLC raised its position in shares of Teladoc Health by 1.5% during the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after buying an additional 56,864 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Teladoc Health in the third quarter valued at about $152,000. Quantinno Capital Management LP lifted its stake in shares of Teladoc Health by 190.4% in the third quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider’s stock valued at $1,709,000 after buying an additional 122,050 shares during the period. Finally, Point72 Asset Management L.P. grew its position in Teladoc Health by 57.8% during the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after buying an additional 3,063,172 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Down 0.8 %

TDOC stock opened at $10.61 on Friday. The firm has a market cap of $1.83 billion, a PE ratio of -1.84 and a beta of 0.97. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $22.54. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The firm has a 50 day simple moving average of $9.70 and a 200 day simple moving average of $9.17.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. The company had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Equities research analysts forecast that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.